Brain Tumour Conference: Register

Brain 2020 conference hero image

Brain Tumour Conference 2020

CORONAVIRUS INFORMATION: CANCER RESEARCH UK EVENTS 

Last updated 13 March, 2020

Important information regarding your registration at the Brain Tumour Conference 2020

Cancer Research UK have been closely monitoring developments relating to the coronavirus (COVID-19) outbreak and reviewing guidance from government bodies.  After careful consideration we have taken the decision not to go ahead as planned, with the Brain Tumour Conference scheduled for 12-14 May 2020.

With the number of attendees, including those travelling internationally, and given that many of you work with vulnerable communities, we agreed that safeguarding your health and safety, and the health and safety of those you work with, is our priority. With global restrictions on international travel continuing to grow, it would not be possible to hold the event in its current format without impacting on the quality of the sessions.

Please review our cancellation policy below. If you have any questions please email researchevents@cancer.org.uk

Important cancellation information

All cancellations must be made in writing to researchevents@cancer.org.uk. We do not accept telephone cancellations.

All registrants are eligible for a full refund of their ticket. If we do not receive a cancellation email, your booking will automatically be transferred to the rescheduled date. If you are unable to attend the rescheduled meeting, please email researchevents@cancer.org.uk to request a full refund.

Cancer Research UK are not liable for any travel or accommodation costs relating to attendee bookings.

Poster and proffered talks

Once a new date for the conference has been confirmed, we ask you to resubmit your abstract for consideration.

Register

Registration includes VAT, networking lunch and coffee breaks on all days, and conference dinner on Wednesday 13 May 2020.
Please note that tickets to the conference dinner are limited, make sure to tick yes to attending when you register to guarantee your space.

Ticket category

Fee

Students

£300

Academics and clinicians

£420

Industry representatives

£700

 

Registration closes on Monday 13 April 2020.

Accommodation is not included in the ticket price. 

Register

Poster abstract submission

All attendees are eligible to submit a poster abstract for the 2020 Brain Tumour Conference. We will accept abstracts from a broad range of topics.

  • Deadline for abstracts is Friday 21 February 2020
  • Applicants will be notified of acceptance on a rolling basis
  • The presenting author of the abstract must register and pay the registration fee
  • An interactive poster viewing will take place during the evening reception on Tuesday 12 May 2020 from 17.10-18.25 and posters will be on display throughout the conference (Please note the date and time is subject to change)

Be part of our Future Leaders session

Date: Wednesday 13 May 2020. Time: from 17.30 Chair: TBC  (Please note the date and time is subject to change)

We're giving post-docs and students the opportunity to showcase their work as part of the conference programme. 

  • 3 Post-docs will have 10 minutes (+5 minutes of questions) each
  • 3 PhD students to have 2 minute lightning talks (2 minutes and 2 slides) each
  • Deadline for abstracts is Friday 21 February 2020
  • Applicants will be notified of acceptance on a rolling basis
  • The presenting author of an abstract must register and pay the registration fee

Sponsors and exhibitors

 

Aurora Callaghan
Research Events Manager
researchevents@cancer.org.uk
Tel +44 (0)203 469 6348

Contact us

If you need more information on the event please contact us:

researchevents@cancer.org.uk

Research opportunities in brain tumours

[Brain icon]

Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".

We're boosting our investment into brain tumours, and we have a number of opportunities to help you develop your brain tumour research or to apply your skills to these cancers for the first time.